Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Equipe Genetique des Anomalies du Developpement, |
RCV002286396 | SCV002576495 | pathogenic | Persistent Mullerian duct syndrome | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV002512931 | SCV003257616 | pathogenic | not provided | 2024-05-28 | criteria provided, single submitter | clinical testing | This variant, c.1332_1358del, results in the deletion of 9 amino acid(s) of the AMHR2 protein (p.Gly445_Leu453del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs764761319, gnomAD 0.09%). This variant has been observed in individuals with AMHR2-related conditions (PMID: 8872466). This variant is also known as ∆27 bp, ∆6331- 6357, and del6331–6357. ClinVar contains an entry for this variant (Variation ID: 8627). Algorithms developed to predict the effect of variants on gene product structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects AMHR2 function (PMID: 19457927, 31291191). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV002286396 | SCV005636866 | pathogenic | Persistent Mullerian duct syndrome | 2024-06-09 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000009159 | SCV000029376 | pathogenic | Persistent mullerian duct syndrome, type II | 2009-08-15 | no assertion criteria provided | literature only |